Medicine Platform

类器官Dexamethasone (DHAP)

  • 收藏 0

Price

  • $69.44元/

普迈精医科技(北京)有限公司
15210409751 4006090003
  • 发货地  
  • 品 牌  类器官/细胞培养/干细胞培养
本公司精品橱窗推荐
  • 资本:未填写
  • 类型:企业单位
  • 主营:显微镜,多功能成像系统,PCR仪,外泌体试剂盒,移液器,冻存耗材,恒温加样台,金属浴
  • 地区:
本页信息为普迈精医科技(北京)有限公司为您提供的“类器官Dexamethasone (DHAP)”产品信息,如您想了解更多关于“类器官Dexamethasone (DHAP)”价格、型号、厂家,请联系厂家,或给厂家留言。
询价 暂无
发货
品牌 类器官/细胞培养/干细胞培养
过期 长期有效
更新 2025-08-12 15:15

类器官Dexamethasone (DHAP)


类器官(Organoids)是指将成体干细胞或多能干细胞在体外三维培养形成的具有一定空间结构的组织类似物。类器官在组织结构、细胞类型、自我更新能力和功能等方面与来源组织高度一致,从而在发育生物学、疾病造模、精准医学、药物研发、基因和细胞疗法、感染和免疫以及再生医学等生物医学的多个领域展现出独特的优势。

产品介绍 DESCRIPTION
Background Dexamethasone is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.
Alias Synonyms,地塞米松,Hexadecadrol,Prednisolone F
M. W t 392.46
Formula C22H29FO5
CAS No 50-02-2
Storage Powder -20°C 3 years                                                                                                                             
In solvent -80°C      2 years                  
Solubility DMSO  250 mg/mL(637.01 mM; ultrasonic and warming and heat to 60°C)
Ethanol  8.33 mg/mL(21.23 mM; Need ultrasonic)
  H2O < 0.1 mg/mL(insoluble)
 
技术参数 BIOLOGICAL ALTIVITY
In Vitro   
Dexamethasone regulates several transcription factors, including activator protein-1, nuclear factor-AT, and nuclear factor-kB, leading to the activation and repression of key genes involved in the inflammatory response[1].
Dexamethasone potently inhibits granulocyte-macrophage colony stimulating factor (GM-CSF) release from A549 cells with EC50 of 2.2 nM. Dexamethasone (EC50=36 nM) induces transcription of the β2-receptor is found to correlate with glucocorticoid receptor (GR) DNA binding and occurred at 10-100 fold higher concentrations than the inhibition of GM-CSF release. Dexamethasone (IC50=0.5 nM) inhibits a 3×κB (NF-κB, IκBα, and I-κBβ), which is associated with inhibition of GM-CSF release[2].
In Vivo  
It has previously been reported that treatment with Dexamethasone at a dose of 2×5 mg/kg efficiently inhibits lipopolysaccharide (LPS)-induced inflammation. In our experimental system, treatment with a single dose of Dexamethasone 10 mg/kg (i.p.) significantly decreases recruitment of granulocytes as well as spontaneous production of oxygen radicals compared with animals expose to LPS and injected with solvent alone (saline). The effects are statistically significant when administered both 1 h before and 1 h after inhalation of LPS. The number of granulocytes in BALF decreased to levels comparable to healthy animals (given an aerosol of water)[3].
公司名 普迈精医科技(北京)有限公司 经营模式未填写
注册资本未填写 公司注册时间2017年
公司所在地 企业类型企业单位 ()
主营行业
主营产品或服务显微镜,多功能成像系统,PCR仪,外泌体试剂盒,移液器,冻存耗材,恒温加样台,金属浴
联系方式
Medicine Platform
 
Disclaimer:
当前页为价格信息展示,该页所展示的批发价格、报价等相关信息均有企业自行提供,价格真实性、准确性、合法性由店铺所有企业完全负责。Medicine Platform对此不承担任何保证责任。
Reminder:
建议您通过拨打厂家联系方式确认最终价格,并索要样品确认产品质量。如报价过低,可能为虚假信息,请确认报价真实性,谨防上当受骗。